These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11512190)

  • 1. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].
    Kronenberg F; Auinger M; Dieplinger H
    Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
    Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
    Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) phenotypes and lipoprotein(a) in type 1 diabetes mellitus patients and their first-degree relatives.
    Cardoso-Saldaña G; Bravo-Rios LE; Torres-Tamayo M; Zamora-González J; Posadas-Romero C
    Rev Invest Clin; 2003; 55(6):662-9. PubMed ID: 15011736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus.
    Shi H; Fang J; Yang X; Shen Z; Zhu X
    Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
    Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
    Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease.
    Sakka Y; Babazono T; Sato A; Ujihara N; Iwamoto Y
    Diabetes Res Clin Pract; 2004 Apr; 64(1):41-9. PubMed ID: 15036826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total plasma homocysteine is associated with hypertension in Type I diabetic patients.
    Neugebauer S; Tarnow L; Stehouwer C; Teerlink T; Baba T; Watanabe T; Parving HH
    Diabetologia; 2002 Sep; 45(9):1315-24. PubMed ID: 12242465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
    J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein a polymorphism predicts lipoprotein a concentration in renal transplant recipients.
    Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Rahbaninobar M
    Transplant Proc; 2005 Sep; 37(7):2925-8. PubMed ID: 16213263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients.
    Chen X; Tian H; Liu R
    Diabetes Res Clin Pract; 2004 Oct; 66(1):41-7. PubMed ID: 15364160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 20210 G to A prothrombin polymorphism and late complications in type 1 diabetes mellitus.
    Humpert PM; Isermann B; Rudofsky G; Ziegler R; Bierhaus A; Ritz E; Nawroth PP
    Thromb Haemost; 1999 Jan; 81(1):164. PubMed ID: 10348712
    [No Abstract]   [Full Text] [Related]  

  • 12. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study.
    Brunkhorst R; Lufft V; Dannenberg B; Kliem V; Tusch G; Pichlmayr R
    Transplantation; 2003 Jul; 76(1):115-9. PubMed ID: 12865796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
    Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
    J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein(a) polymorphism and its association with plasma lipoprotein(a) levels: a north Indian study.
    Vasisht S; Gulati R; Srivastava LM; Narang R; Chopra V; Srivastava N; Agarwal DP; Manchanda SC
    Indian Heart J; 2000; 52(2):165-70. PubMed ID: 10893891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin phenotype and vascular complications in patients with diabetes.
    Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
    N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
    [No Abstract]   [Full Text] [Related]  

  • 17. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Cardiovasc Risk; 1998 Feb; 5(1):37-42. PubMed ID: 9816554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate.
    Earle KA; Mattock M; Morocutti A; Aravanitis D; Viberti GC
    Diabet Med; 1996 Dec; 13(12):1071-2. PubMed ID: 8973890
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
    Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
    J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.